Litcius/Paper detail

Decylprodigiosin: a new member of the prodigiosin family isolated from a seaweed-associated Streptomyces

Mariana Girão, Sara Freitas, Teresa P. Martins, Ralph Urbatzka, Maria F. Carvalho, Pedro N. Leão

2024Frontiers in Pharmacology11 citationsDOIOpen Access PDF

Abstract

Bioprospecting actinobacterial secondary metabolism from untapped marine sources may lead to the discovery of biotechnologically-relevant compounds. While studying the diversity and bioactive potential of Actinomycetota associated with Codium tomentosum, a green seaweed collected in the northern Portuguese cost, strain CT-F61, identified as Streptomyces violaceoruber , was isolated. Its extracts displayed a strong anticancer activity on breast carcinoma T-47D and colorectal carcinoma HCT116 cells, being effective as well against a panel of human and fish pathogenic bacteria. Following a bioactivity-guided isolation pipeline, a new analogue of the red-pigmented family of the antibiotics prodigiosins, decylprodigiosin (1), was identified and chemically characterized. Despite this family of natural products being well-known for a long time, we report a new analogue and the first evidence for prodigiosins being produced by a seaweed-associated actinomycete.

Topics & Concepts

BiologyStreptomycesBioprospectingMicrobiologyAntimicrobialAlgaeAntibioticsBacteriaBotanyGeneticsMicrobial Metabolism and ApplicationsMicrobial Natural Products and BiosynthesisTannin, Tannase and Anticancer Activities